SPI
CLB icon

Santori & Peters Inc’s Core Laboratories CLB Stock Holding History

Santori & Peters Inc’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-111
Closed -$11K – 148
2017
Q4 		$11K Buy
+111
New +$11.1K 0.01% 276

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Santori & Peters Inc's CLB Position: Q1 2018 in Review

Santori & Peters Inc sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 111 shares — an estimated $11K sold.

Santori & Peters Inc first reported a position in CLB in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Santori & Peters Inc reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Santori & Peters Inc sold 111 Core Laboratories shares in Q1 2018, an estimated $11K.
  • Santori & Peters Inc first reported a position in Core Laboratories in Q4 2017 and held it in 1 quarter.
  • Santori & Peters Inc's Core Laboratories position peaked at $11K in Q4 2017.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.